Standards Reference
Doxycycline Hyclate (TRC-D561500-50MG)
Sinônimos: Monodoks, Periostat, Ethanol, compd. with [4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2), monohydrate, Tetraclean,Doxycycline Hyclate, 6-Desoxy-5-hydroxytetracycline hydrochloride hemihydrate hemiethanolate, Doxyprex, BioPure MTAD, 2-Naphthacenecarboxamide, 4beta-(dimethylamino)-1,4,4abeta,5,5abeta,6,11,12a-octahydro-3,5beta,10,12,12abeta-pentahydroxy-6beta-methyl-1,11-dioxo-, monohydrochloride, compd. with ethyl alc. (2:1), monohydrate (8CI), Ethanol, compd. with (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2), monohydrate (9CI), Doxycycline hydrochloride hemiethanolate hemihydrate, Atridox, WC 2031, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol (2:1), monohydrate (9CI), Doxycycline hyclate, Doxitrat, DOX-T 100, DOXY 100, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha)]-, compd. with ethanol (2:1), monohydrate
Descrição EP:
Código do Produto:
TRC-D561500-50MG
Número CAS:
24390-14-5
Product Categories:
API standards Matrix metalloproteases Pain and Inflammation Tetracyclines TRC
API Family:
Doxycycline Hyclate
Product Types:
API
Formato do Produto:
Neat
Fórmula Molecular:
Peso Molecular:
Choose quantity:
Quote Change Quantity Remove from QuoteNOTE: Click the "Quote" button to include this product in your quote.
NOTE: Click the "Change Quantity" button to change the quantity of this product in your quote.
NOTE: Click on the button "Remove from Quote" this product will be deleted from your quote.
